Phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual-agent approach targeting immunosuppressive polyamine metabolism. [PDF]
ESMO OpenPiha-Paul SA +4 more
europepmc +1 more source
Clinical characteristics and treatment outcomes of neuroblastoma with pulmonary metastases. [PDF]
World J Pediatr SurgWei Q +8 more
europepmc +1 more source
In Silico Screening of <i>Cannabis sativa</i> Phytochemicals as Potential Ornithine Decarboxylase Inhibitors for Anti-Leishmanial Drug-Prioritized Compound Development. [PDF]
Biology (Basel)Khan AH +9 more
europepmc +1 more source
Development of a multidimensional disease burden assessment system for childhood neuroblastoma based on the social determinants of health theory. [PDF]
Front OncolBan X, Chong Q, Shao W, Liu W, Peng M.
europepmc +1 more source
Metabolic cooperation supports mutual growth between the protozoan parasite Trichomonas vaginalis and dysbiotic vaginal bacteria. [PDF]
PLoS PathogHinderfeld AS +4 more
europepmc +1 more source
Spermine Synthase at the Polyamine-Redox Interface: Mechanistic Evidence from Snyder-Robinson Syndrome and Cancer. [PDF]
Antioxidants (Basel)Lin Z, Lin Y, Li M, Zhan S, Xu Q, Yu F.
europepmc +1 more source
Citrullinated histone H3 and elevated polyamine metabolism gene expression in peripheral blood polymorphonuclear leukocytes as biomarkers for poor immunotherapy response in cancer patients. [PDF]
Mol BiomedAnzovino A +5 more
europepmc +1 more source
Covalent Inhibitors in Antimicrobial Drug Development-Beyond β-Lactams. [PDF]
MoleculesJafari G, Duncan D.
europepmc +1 more source
Controlling Epileptic Activity by Modulating Putrescine Metabolism. [PDF]
BiomoleculesQahtan S +4 more
europepmc +1 more source
Correction to "The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma". [PDF]
Mol Oncoleuropepmc +1 more source